European Bioanalysis Forum (EBF) - Welcome to our virtual booth

Welcome to the Drug Development Solutions virtual booth for EBF.

Here you will find details on our services, downloadable content and who to contact.

COVID-19 Antibody Analysis via Serum and Dried Blood

Our Covid-19 antibody assay now holds CE Mark and has ISO17025 accreditation pending.
Samples are taken remotely without the need for professional healthcare workers.
Our assay is suitable for both serum and dry blood sampling using Neoteryx’s Mitra® device.


Please see our accepted Drug Development Solutions presentations listed below:

Centres of Excellence

Alongside a suite of immunochemistry and cell based
platforms, our Protein LC-MS service can play a crucial role in drug development through monitoring the pharmacodynamics with a biomarker, the pharmacokinetics of a pharmaceutical or its immunogenicity.


Our Immunogenicity Centre of Excellence is built upon a wealth of experience in the development and validation of sensitive, specific, selective and drug tolerant assays to measure anti-drug antibody (ADA) responses to therapeutic protein products.


To find out more about our Drug Development Solutions Centres of Excellence please do not hesitate to contact us or download our fact sheets.


Visit our resource library to see a wider range of downloadable content.

Our Drug Development Solutions colleagues below will be on hand throughout the event to help with any questions you may have. Please feel free to contact them.

 Michael van der Merwe
 Commercial Director
 +44(0)7787 551127

 Zafar Alam
 Associate Director, Business Development
 +44 (0)7867 670464

 Myriem Aftis
 Business Development Manager
 +44 (0)7408 806106

 Nicola Hickson
 Account Manager, Business Development 
 +44 (0)7900 743884

 Stephen Craycraft
 Associate Director 
 +44 (0)7408 859221